DCM
ABBV icon

Dorato Capital Management’s AbbVie ABBV Stock Holding History

Dorato Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
4,149
+50
+1% +$10.8K 0.7% 31
2026
Q1 		$867K Sell
4,099
-27
-0.7% -$5.99K 0.64% 37
2025
Q4 		$916K Buy
+4,126
New +$940K 0.69% 34

Other funds holding ABBV

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Dorato Capital Management's ABBV Position: Q2 2026 in Review

Dorato Capital Management increased its AbbVie (ABBV) stake by 1.2% in Q2 2026, buying an estimated $10.8K and bringing the position to 4,149 shares worth $1.03M. The position accounts for 0.7% of the portfolio, ranked #31.

Dorato Capital Management first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 2,661 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Dorato Capital Management held 4,149 shares of AbbVie worth $1.03M as of Q2 2026.
  • Dorato Capital Management bought 50 AbbVie shares in Q2 2026, an estimated $10.8K.
  • AbbVie made up 0.7% of Dorato Capital Management's portfolio in Q2 2026, its #31 holding.
  • Dorato Capital Management first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 2,661 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Dorato Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.